Registering for participation is easy! If you are interested in a particular study, the best way to register is to use the contact form on the respective study page. You can find a list of all our studies here.
If we are currently not conducting a study that is of interest to you, you can register here in our database. We will then notify you when a suitable study starts.
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
The conduct of clinical trials is subject to strict regulations and ethical guidelines. All of our trials are submitted to and approved by a research ethics committee in the UK. The safety of the participants is paramount at all times. While all medical interventions involve a degree of risk, safety measures are taken in the design of each study to minimise potential risks. Participants are informed of potential risks before agreeing to participate, and trials are closely monitored by medical professionals and regulatory authorities to ensure safety throughout the process. If at any point you wish to withdraw from the trial, you can, of course, do so.
Compensation varies from trial to trial. However, you can expect compensation for your travel expenses. In addition to reimbursement of travel expenses, you will often also receive an expense allowance as approved by an ethics committee. You will be informed of the amount of compensation before attending.
The trials are usually conducted at one of our study sites. We currently have four locations in the UK: Birmingham, Liverpool, Glasgow and Teesside. To find a location near you, go to "Study Sites" in the menu.
FutureMeds UK and our network of international study sites have a data protection officer and consistently adhere to all national and international data protection laws. This means that we only pass on anonymised disease data to our clients that is required for the assessment of drug effects. Names and address data are never passed on to customers, advertising companies or other potential interested parties. In addition, all FutureMeds employees are naturally subject to medical confidentiality.
FutureMeds cannot offer you private medical treatment after the end of the study. However, we will support you by working with your GP. Our doctors will provide you with comprehensive advice and your GP will receive a progress report on your participation in the study.
This depends on the phase of the respective study. In most cases, in phase I, II and III trials, drugs are tested that have not yet been authorised. Phase IV studies investigate specific issues with drugs that have already been authorised. Occasionally, we also conduct studies in which the drugs are not yet authorised in Europe, but are already available in pharmacies in other countries. Of course, you will be informed of the current research stage of the drug before you take part in a trial.